[毛囊淋巴瘤的分子病原和治疗]
1Human Health Sciences, Graduate School of Medicine, Kyoto University.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
毛囊性淋巴瘤 (FL) 呈现出不同的临床行为. 分子分析和新型疗法 (如CAR-T细胞) 的进步正在改善患者的治疗结果,但治疗效率各不相同.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 毛囊性淋巴瘤 (FL) 呈现出广泛的临床谱,从惰性疾病到耐火性疾病.
- 组织学转变为攻击性亚型显著恶化了生存结果.
- 了解FL的分子病原性对于有效治疗至关重要.
研究的目的:
- 审查了解FL分子生物学方面的最新进展.
- 讨论超越传统免疫化学疗法的新疗法策略.
- 突出FL患者需要个性化治疗方法的需要.
主要方法:
- 关于FL分子分析 (DNA,RNA) 的当前文献的综述.
- 在FL的瘤微环境研究分析.
- 评估新兴疗法,包括小分子,双特异抗体和CAR-T细胞疗法.
主要成果:
- 分子分析提高了对FL病变的理解.
- 新型疗法为FL患者提供了改善的预后和扩展的治疗选择.
- 治疗疗效和预后因素可能因治疗剂而异.
结论:
- 对FL分子生物学有更深入的了解是必不可少的.
- 需要根据分子形状量身定制的个性化治疗策略.
- 优化治疗序列有望改善FL患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


